Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.07 USD | -2.54% | -6.40% | +51.98% |
10/05 | Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target | MT |
08/05 | Transcript : Aquestive Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.98% | 279M | |
+38.69% | 728B | |
+33.12% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+15.82% | 244B | |
+7.98% | 207B | |
-5.32% | 205B | |
+6.42% | 164B |
- Stock Market
- Equities
- AQST Stock
- News Aquestive Therapeutics, Inc.
- Leerink Partners Starts Aquestive Therapeutics With Outperform Rating, $8 Price Target